Pediatric Vitrectomy Market is Segmented By Treatment (Pars Plana Vitrectomy, Anterior Eye Vitrectomy), By Product(Laser System, Probes, Phacoemulsifiers System, Others), By Indication(Macular holes, Vitreous hemorrhage, Retinal detachment, Cataract, Vitreous floaters, Others), By End-User(Hospitals, Clinics, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) â Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Pediatric Vitrectomy Market is Expected to reach at a CAGR of 6.4% during the forecast period (2023-2030). Pediatric Vitrectomy is a surgical procedure used to remove the vitreous gel from the middle of the eye in children. There are two types of vitrectomy: pars plana vitrectomy and anterior eye vitrectomy. Pars plana vitrectomy is used to treat endophthalmitis, retinal detachment, and vitreous hemorrhage in the patient's eye. In contrast, the eye's anterior chamber is treated with anterior eye vitrectomy.
Pediatric Vitrectomy Market
|
Metrics |
Details |
|
Market CAGR |
6.4% |
|
Segments Covered |
By Treatment, By Product, By Indication, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Market Dynamics
The global pediatric vitrectomy treatment market growth is driven by the increasing instances eye and vision disorder cases across the globe, increase in awareness of treatment option for eye disorder cases,favorable reimbursement polices.
The increase in prevalance of vision disorders in the market will drive the market growth
One of the paramount factors driving the growth of the pediatric vitrectomy market is the increasing number of children suffering from various vision and eye disorders. The growing demand for noninvasive vitrectomy surgery procedures propels the pediatric vitrectomy market. The development of new and advanced vitrectomy systems is also expected to contribute to the growth of the pediatric vitrectomy market. The pediatric vitrectomy market is expected to benefit from rising public awareness of the importance of safe and effective vitrectomy surgical procedures. Government initiatives to improve treatment and reimbursement policies are fueling the growth of the pediatric vitrectomy market. Products in the pipeline are expected to drive the pediatric vitrectomy market's growth over the forecast period.
This contributes to the growth of the Global Pediatric Vitrectomy market.
Rise in risk of infections is likely to hamper the market growth
Side effects of the pediatric vitrectomy procedure include bacterial infection, inflammation, bleeding inside the eyes, cataract formation or progression of existing cataracts, and increased pressure (glaucoma) or decreased pressure in the eye. Furthermore, to treat the serious condition of the eye during surgery, silicone oil is used as a vitreous substitute, which can impair the patient's vision for weeks or months, necessitating another procedure to remove the silicon oil after several months of pediatric vitrectomy. Furthermore, recovery from eye surgery is more difficult because patients must deal with the stress and discomfort of being in a facedown postoperative position for 23 hours a day. These factors are expected to limit the growth of the global pediatric vitrectomy market.
COVID-19 Impact Analysis
COVID-19 had an impact on every industry and sector around the world. According to the Indian Journal of Ophthalmology, May 2020, there is a high level of anxiety and stress among ophthalmology trainees due to the disruption in training procedures caused by COVID-19. Furthermore, according to the U.S. National Library of Medicine June 2020, various parts of patients touching the ophthalmic equipment can lead to the risk of COVID-19 infection spreading through aerosolized particles, negatively impacting the global pediatric vitrectomy market.
Segment Analysis
The laser system segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
Over the projection period, the laser system segment is expected to increase . Due to the increased demand for non-invasive surgery, laser systems have a substantial market share among product types. Laser vitreolysis is a non-invasive therapy that employs laser light to break up opacities in the vitreous. The rising number of vision disorders, the rising cases of cataract, and the rising frequency of diabetes retinopathy contribute to the segment's rise. For example, approximately 12 million people aged 40 and up have vision impairment in the United States, with approximately a million blind. Globally, the statistics are similar, with the World Health Organization reporting that over 2.2 billion people have eye and vision problems.
Furthermore, According to the CDC, 17.2 percent of Americans over the age of 40 have a cataract in at least one eye (about 20.5 million people). Cataracts are expected to affect over 30 million people by 2028. The Central for Disease Control and Prevention estimates that 4.1 million Americans have diabetic retinopathy, and nearly 900,000 are at risk of vision-damaging retinopathy. The pediatric vitrectomy market is expected to benefit from rising public awareness of the importance of safe and effective vitrectomy surgical procedures. Government initiatives to improve treatment and reimbursement policies are fueling the growth of the pediatric vitrectomy market.
Geographical Analysis
North America region holds the largest market share of Global Pediatric Vitrectomy Market
North America is expected to have a significant market share in the global pediatric vitrectomy market, owing to the rising prevalence of retinopathy of prematurity (ROP) among infants, which causes vision impairment and blindness. According to the NIH July 2019 report, approximately 14,000 to 16,000 infants in the United States were affected by retinopathy of prematurity (ROP), which is expected to lead to vision impairment and blindness in severe cases.
For example, in 2019, Bausch + Lomb, a U.S. eye health product company, launched 23 gauge Bi blade dual-port vitrectomy cutters with an efficiency of 15,000 cuts per minute rate, which increases cutting flow efficiency in ophthalmic surgeries when compared to guillotine cutters.
The increasing prevalence of cataracts among children in Europe is propelling the growth of pediatric vitrectomy procedures in infants. According to the National Health Service (NHS) 2018 report, approximately 3 to 4 infants out of every 10,000 were affected by cataracts in the United Kingdom. Over the forecast period, these factors are expected to drive significant growth in the European pediatric vitrectomy market.
Competitive Landscape
The pediatric vitrectomy market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Alcon, Leica Microsystems GmbH, Orion Media, Bausch & Lomb, Carl Zeiss Meditec AG,Optos PLC, Lumenis Ltd, Synergetics ,Inc,Novartis, Danaher, Nikon, Zeiss.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the blood and blood products market globally. For example, Bausch + Lomb, a U.S. eye health product company, launched Bi blade dual-port vitrectomy cutters with '25-gauge and 27-gauge' used in Stellaris Elite vision enhancement system 2018. (intended for emulsification and removal of cataracts). Compared to guillotine cutters, this product has a rate of 15,000 cuts per minute, increasing cutting flow efficiency in surgery.
Also, in 2019, Alcon launched New Vitrectomy Probe and Next Generation NGENUITY 3D visualization system at the American Society of Retina Specialists meeting.
Bausch & Lomb
Overview: Bausch + Lomb is a company that manufactures eye care products and is headquartered in Rochester, New York, USA. It is a major supplier of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products around the world.
Product Portfolio:
Vitesse Hypersonic vitrectomy : The Vitesse hypersonic vitrectomy system (Bausch + Lomb) comprises a 23-gauge vitrectomy probe and a 33-mm stainless steel needle with a 255-m teardrop port at the tip that oscillates with user-controlled amplitude. The Vitesse vitrectomy handpiece generates fluidic and mechanical cutting action by using ultrasonic, harmonic needle tip movement at 28.5 kHz to fragment and remove vitreous.